157 related articles for article (PubMed ID: 15499286)
41. Retinopathy after irradiation for Graves' ophthalmopathy.
Nikoskelainen E; Joensuu M
Lancet; 1989 Sep; 2(8664):690-1. PubMed ID: 2570949
[No Abstract] [Full Text] [Related]
42. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors.
Parsons JT; Bova FJ; Fitzgerald CR; Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):765-73. PubMed ID: 7960977
[TBL] [Abstract][Full Text] [Related]
43. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
[TBL] [Abstract][Full Text] [Related]
44. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
45. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ
Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885
[TBL] [Abstract][Full Text] [Related]
46. An update on medical management of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Piantanida E; Lai A; Marinò M; Pinchera A
J Endocrinol Invest; 2005 May; 28(5):469-78. PubMed ID: 16075933
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical staining of normal and Graves' extraocular muscle.
Tallstedt L; Norberg R
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
[TBL] [Abstract][Full Text] [Related]
48. [Clinical evaluation of radiotherapy for endocrine ophthalmopathy].
Okada K; Oshitani T; Mieda C; Ogawa K; Maruta T; Ikeda Y; Suematsu T; Hirata Y; Obayashi K; Ishida T
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):649-54. PubMed ID: 2235315
[TBL] [Abstract][Full Text] [Related]
49. Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy.
Li YJ; Luo Y; He WM; Li P; Wang F
Radiat Oncol; 2017 Nov; 12(1):171. PubMed ID: 29110673
[TBL] [Abstract][Full Text] [Related]
50. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
[TBL] [Abstract][Full Text] [Related]
51. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Manetti L; Tanda ML; Dell'Unto E; Rocchi R; Cartei F; Pinchera A
Thyroid; 1998 May; 8(5):439-41. PubMed ID: 9623740
[No Abstract] [Full Text] [Related]
52. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy.
Miller ML; Goldberg SH; Bullock JD
Am J Ophthalmol; 1991 Nov; 112(5):600-1. PubMed ID: 1951605
[No Abstract] [Full Text] [Related]
53. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
Przegl Lek; 2004; 61(8):852-4. PubMed ID: 15789915
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.
Wiersinga W; Prummel MF
J Clin Endocrinol Metab; 1995 Feb; 80(2):345-7. PubMed ID: 7852487
[No Abstract] [Full Text] [Related]
55. Radiotherapy for Graves' ophthalmopathy: current treatment recommendations.
McDougall IR; Donaldson SS
Front Radiat Ther Oncol; 2001; 35():57-64. PubMed ID: 11351953
[No Abstract] [Full Text] [Related]
56. Cigarette smoking and treatment outcomes in Graves ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Manetti L; Dell'Unto E; Bartolomei MP; Nardi M; Martino E; Pinchera A
Ann Intern Med; 1998 Oct; 129(8):632-5. PubMed ID: 9786811
[TBL] [Abstract][Full Text] [Related]
57. [Complications during systemic corticosteroid therapy combined with orbital radiotherapy in patients with graves orbitopathy].
Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
Przegl Lek; 2004; 61(8):855-6. PubMed ID: 15789916
[TBL] [Abstract][Full Text] [Related]
58. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
[TBL] [Abstract][Full Text] [Related]
59. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy.
Nygaard B; Specht L
Lancet; 1998 Mar; 351(9104):725-6. PubMed ID: 9504522
[No Abstract] [Full Text] [Related]
60. [The role of radiotherapy in endocrine orbitopathy].
Feyerabend T; Richter E; Buschmann W; Becker W; Herbolsheimer M; Pingel B
Klin Monbl Augenheilkd; 1989 Jul; 195(1):1-6. PubMed ID: 2796225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
